Peer Review History
| Original SubmissionMay 13, 2022 |
|---|
|
PONE-D-22-14066A new paradigm for personal protection against ticks: efficacy of spatial repellents to reduce host seeking activities in three major tick species of medical importancePLOS ONE Dear Dr. Rich, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers were generally positive about the potential for this work but had concerns about the clarity of the manuscript. Please address the comments carefully and provide the level of detail the reviewers have asked for. Please submit your revised manuscript by Sep 09 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Catherine A. Brissette, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was supported by the DoD Tick-borne Disease Program from the Congressional Directed Medical Research Program, grant # W81XWH1920028.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study presents a unique bioassay that evaluates the response of three medically important tick species in the US to various volatilized AIs. As noted in the manuscript, development of such bioassays is an important first step in evaluating candidate AIs for use as spatial repellents. However, it is difficult to compare actual efficacy among the compounds used because only a single concentration was applied per compound (though clearly the assay provides a concentration gradient). I would suggest rethinking the title of the manuscript. The findings are essentially a description of a novel bioassay, which is very significant, but they do not actually show the “efficacy of spatial repellents to reduce host-seeking activity” as a new paradigm for personal protection. The assay seems effective at screening different AIs, but wonder if a concentration gradient should have been used for each AI. It is possible that the optimal concentration is not the same across compounds and this should be noted in the Discussion as a limitation. I’m not sure how transferable this information is to a natural setting. I realize scaling efficacy trials is a goal for future studies, but the title of the paper suggests a more definitive answer would be presented herein. This would also be worth a bit more discussion. Overall, this was a clearly written manuscript describing a novel bioassay. A few minor points are listed below. Line 205: Why were ticks that did not move during the trials omitted? Maybe I’m not understanding the methods as written, but it sounds like you first screened ticks in the absence of AIs to ensure they were willing to ascend sticks. If that’s the case, why omit the ones that didn’t move in the presence of an AI? Seems lack of movement would be a valid response if the tick is at the bottom of the stick and chooses not to ascend away from the repellent? Please provide additional explanation for why these were excluded and what immobility might imply about the efficacy of the compound. Results (and Tables): If the data are analyzed using non-parametric statistics due to a lack of normality, why present the results as means and standard deviations, rather than medians and ranges? Reviewer #2: This manuscript presents results of experiments that tested the impacts of exposure to 4 repellents (nootkatone, DEET, transfluthrin, metafluthrin) on the behavior of 3 species of ticks, Amblyomma americanum, Dermacentor variabilis, and Ixodes scapularis. Each species is evaluated for the impacts of spatial exposures rather than contact responses. The authors also describe the bioassay apparatus and developed several metrics to assess behavior, using video capture as a tool for these analyses. Major weaknesses include: 1. The idea of non-contact spatial repellency is not a new paradigm. Others have considered and reported evaluation of this for ticks. Ticks Tick Borne Dis. 2017 Oct;8(6):837-849.doi: 10.1016/j.ttbdis.2017.06.010. Epub 2017 Jul 1. 2. Simulations of spatial gradients in the chamber were only done with metafluthrin and transfluthrin. Why weren’t DEET and Nootkatone assessed? 3. The results are confounded because some of the ticks were collected in the environment (wild-caught) and some were purchased from a rearing facility in Oklahoma. There is no description of the relative proportions of the wild-caught vs colony ticks used for the assays and no validation that colony ticks performed in the same way as wild ticks. This matters because the genetic background of the OSU ticks is unknown. We do know that southern versus northern Ixodes scapularis ticks do not behave in the same way and this has a genetic component (Arsnoe et al. 2015). Field caught ticks may also have other conditions that could affect behavior, including infection status and physiological age. A better study design would be to compare an adequate sample of ticks from the lab colony with a similar number of ticks collected from a field site. Mixed samples are not acceptable unless adequate testing has been done to assure the colony and wild specimens behave identically. 4. No variance estimates for some of the metrics are provided. Did ticks perform the same between the 4-6 replicates? 5. Some of the reported outcomes lump all species together (Table 1 and in-text). This is not appropriate given the differences that were observed. 6. The authors do not clearly describe how they expect these materials to be used. Spatial repellents for mosquitoes work for malaria control because mosquitoes enter homes and bite humans there so repellents can protect entry points of the homes. Spatial repellents for humans doing yardwork or hiking don’t work to reduce mosquito bites because the volatile cloud produced by a personal device isn’t stable. A clearer description of how they envision spatial repellents working to prevent tick bites would be useful for readers. The manuscript is not well-written or well-edited. There are multiple places where the wording is incorrect, unclear or so imprecise as to be uninterpretable. Errors of grammar and formatting are common throughout this manuscript. Some of the many examples of these problems include: Abstract 1. Line 30: “of Integrative Vector Management (IVM) program”. Either “an IVM program” or “IVM programs” 2. Line 30: The accepted term is Integrated Vector Management, not integrative. 3. “…despite the speculated value of volatilized chemicals in control systems.” Who is speculating? A reference is needed. Or consider “potential value”. 4. “…novel vertical climb assay”. What makes the assay novel? Others have used vertical sticks in arenas to study tick questing behavior. Others have filmed vertical movement behavior and analyzed it. Consider simply describing the assay without the qualifier. 5. Line 41: “…and changing in tick climbing behavior when compared controls“ Grammatically incorrect. 6. Line 45: “slightly weaker effects “. This does not accurately reflect observations. DEET and Nootkatone appeared to be more effective for I. scapularis. Compare with lines 372-376 “Exposure to all four AIs was associated with significant reductions in pseudo-questing tendency in D. variabilis and A. americanum. This association was strongest with metofluthrin and transfluthrin in both species. In I. scapularis, nootkatone showed the strongest effect, however DEET and metofluthrin showed smaller, significant reductions. Only transfluthrin was not associated with a significant reduction.” Introduction 1. Line 55-57. “The prevalence of these zoonotic diseases has increased recently due to shifts in host population dynamics, particularly with the white-tailed deer, that affect tick population size [2]. “ Many would dispute this assertion that white-tailed deer are the primary drivers of recent increases in tickborne disease prevalence. Many studies have failed to find a strong correlation between deer abundance and tickborne diseases like Lyme disease. Human behavior and exposure is a key issue. Defining "recent" could help place this in context-last hundred years? 2. Line 57-58: “Targeting of live arthropod populations…” The word “live” is unnecessary. The rest of the sentence could be restated as “an important component of integrated vector management program is vector management”. I’m struggling to understand what component of IVM would not involve targeting the vectors, whether they are on or off hosts. 3. Line 60: “source reduction” has a specific meaning in vector biology-the elimination of breeding sites for mosquitoes (or vectors without aquatic life phases). Using the term to mean all types of environmental control as opposed to personal prevention muddies the definition and should be avoided. 4. Line 62-63: “…while personal protective methods seek to reduce risk to individual humans through smaller-scale, personal chemical application.” Again, this statement lacks precision. Most tick biologists consider personal protective methods to be broader than just personal chemical application. Such methods also include tick checks, showering soon after potential exposure, tucking pants into socks, and putting clothes in a hot dryer after being outside. 5. Line 73-75. “The host-seeking behavior and ecology of ticks, however, challenges the applicability of these repellent biomechanisms that are traditionally used to combat more agile, flying arthropods.” The authors should be specific about why ticks would not be expected to exhibit inhibition of attraction to a host, irritancy, or intoxication as a result of exposure to a repellent, simply because they don’t fly. The DEET example shows that the mechanisms may change, not that they are not applicable. 6. Line 80. “Other known pyrethroids….” This paragraph/sentence structure makes it sound like the authors are saying DEET is a pyrethroid. 7. Line 82. Again, the use of “source reduction” does not align with practices in the field. ULV is mostly used for adulticiding, not for source reduction (targeting larval sites). The next sentence makes clear that it is targeting adults with ULV that the authors are referring to. 8. Line 86-88. Please clarify the statement to reference lack of standardized assays for spatial repellents as opposed to contact repellents and cite the papers that do define standard assays for assessing contact repellents for ticks. The US EPA and the UK both have defined acceptable assays for regulatory processes. You should also cite the papers that have looked at spatial repellency for ticks, e.g. for permethrin treated clothing. Results 1. “Few A. americanum detached from their sticks in control trials (2) however only once reaching the top, and no I. scapularis or D. variabilis in theirs. (Table I).” This sentence needs rewriting for clarity. Discussion. 1. Line 367-368. “Thus, they must use this supply wisely” Line 396. “…..desired location”. Avoid words like ‘wisely’ and ‘desired’ in describing tick behavior. 2. Line 383-385. “There were several occurrences of large changes in the distance ticks traveled. The greatest of which were with metofluthrin and transfluthrin, which reduced the displacement of all three species.” Sentence fragment. 3. Line 392-394. “The reduction in velocity shown by metofluthrin and transfluthrin in D. variabilis and A. americanum could be evidence of visual effects of AI interference in ticks’ natural ability to move.” Could the authors clarify how AI would interfere with tick vision? 4. Line 399-412. How would a tick experience the gradient? Considering size of a tick relative to volume of the container and behavior of the AI materials, would you expect a tick at the bottom to sense a gradient? To reiterate, these are just examples of problematic statements, language, and editing. There are many more. Much of the paper needs a major overhaul. Reviewer #3: PLOS ONE Manuscript No. PONE-D-22-14066 Authors: Siegel EL, et al. Many of the explanations and descriptions given in this manuscript were weak and appeared rather hurriedly done. The title of the manuscript claims that this work represents a new paradigm in evaluating spatial repellents to ward off tick parasitism. Such a paradigm will be welcomed by many. But if this work is to truly present a new way forward, then everything – from describing and illustrating the apparatus to providing methods of calculating and analyzing outcome variables – needs to be explained in a more clear and concise manner. Some of the ways this can be done are listed below. There were 6 behavioral outcomes (i.e., dependent variables) used to assess the spatial repellency of 4 different volatiles. Some of the variables (e.g., climbing success versus climbing height reduction) appeared to be highly interdependent. The manuscript would increase its usefulness to other vector biologists if authors could either rank the variables or make a recommendation, based on their experience, on which of the six might are the most useful and meaningful to employ when testing volatiles for spatial repellency of host-seeking ticks. INTRODUCTION. Lines 102-103. This is the last sentence in the final paragraph of the Introduction where authors typically state the research objective of their study. But the sentence construction here is jagged. There are several dependent clauses all strung together at the end of an already long sentence. This tends to muddle the meaning. Suggest condensing or break it into two sentences. MATERIALS & METHODS Description of the apparatus needs improvement. For example: - Line 126. Is a ‘chemical-emanating device’ the same as a ‘controlled release device’? If so, then please refer to the device using a single, consistent term. Otherwise, it is confusing. - Line 129. Before describing the behavioral test chamber, it is appropriate to provide a description of the controlled release device. - Figure 1. Please provide dimensions of the controlled release device. - Line 135. “placement of the active ingredient” – shouldn’t that be “placement of the CRD containing the AI being tested”? - Line 138. Please state the composition of the sticks. Wooden sticks? Plastic sticks? Paper sticks? - Figure 2 legend; Line 148. Change the word ‘device’ to ‘controlled release device [CRD]” so that it matches what is shown in the diagram. - Line 159. Again, is the term ‘emanating device’ the same thing as the ‘controlled release device’? Please use consistent terminology throughout. - Line 182 – Video Tracking. EthoVision is a software program. Please provide brief description of the hardware and conditions used – e.g., camera, level of magnification if any, etc. This can be provided as a Supplement section. RESULTS – 6 outcome variables. WHICH IS THE MOST IMPORTANT ?? Tables – keep the order of tick species consistent – e.g., Amblyomma – Dermacentor – Ixodes. Mixing the order all around from one table to the next adds unnecessary confusion for the reader. Figures. – similarly, keep the order of the test compounds consistent from table-to-table and figure-to-figure (e.g., Fig. 5 differs from Figs. 6-8). OUTCOME VARIABLES Tick Detachment – Table 1 Authors should point out that none of the 4 AI’s significantly altered detachment for A. amblyomma. The significant effect of metofluthrin on tick detachment was due solely to the response of D. variabilis and I. scapularis ticks. Thus, the statement on line 416 is incorrect. With A. americanum and metofluthrin, detachment in the control group was 2/15. Detachment in the metofluthrin group was 3/15 (Table 1). No difference. Mean displacement – Table 2 - Data were not normally distributed (lines 201-202). Therefore, values should be presented as geometric means and 95% CL, not arithmetic means + SD. Climbing height reduction – Fig. 5 – What do the numbers signify atop each histogram ? Percentages? They should also indicate the sample size. Line 192. Climbing height reduction needs to be more fully explained – e.g., how were heights of AI-exposed ticks ‘normalized’ to non-exposed control ticks? Was there some kind of mathematical formula used? If so, please provide. Climbing Success – Fig. 6 – what is the difference between Climbing Success and Climbing Height Reduction. This should be explained clearly because the pattern of histograms (Fig. 5 & Fig. 6) appear nearly identical for two of the three tick species. Are you showing the same thing or something different in Figs. 5 & 6. This should be made clear. Much of the text in Figure legends – Fig. 6, 7, 8 – should be taken out of the figure legends and placed in the appropriate place within the text of Results section. FIGURES 3, 4, 7 & 8. The axes labels are too small and need to be enlarged to be legible. FIGURE 3a & 3b. No exaggeration, I had to use a magnifying glass to read the labels on the y-axes. The x-axis was not labelled at all. Where is the CRD placement in relation to the configuration of this chart? Presumably at top left corner for larger box, but at top right for smaller box? This needs to be clarified. FIGURE 7. Likewise, the font chosen to express significance level is too small. TABLE 3. Use a footnote or some other way to denote what the asterisks signify. Also, use a zero to the left of the decimal point, otherwise a reader might overlook the small little dots (decimal points) in a table containing 12 rows of data. Line 204. States that all ticks were included. But lines 174-175 states that some ticks were excluded. Which is correct? DISCUSSION Line 347 – What is meant by the phrase “build on the shortcomings”? Building anything new based on the defective ideas/practices of the past does not a seem like the best approach for progress. Is this really what the authors meant to say? Line 408 – “pushing ticks to continue questing for a safer place”? Not sure what this means. Is there any evidence to support the notion that ticks are sentient enough to sense danger? Perhaps it is better to frame this in terms of a mechanistic response to volatiles Lines 462-464. The ideas contained in this sentence are not relevant to a discussion of spatial repellents distributed by controlled release devices. To avoid confusing the use of personal repellents with spatial repellents, this sentence should be removed. MINOR GRAMMATICAL & MISCELLANEOUS Line 65. Add word “repellent” between the words ‘spatial’ & ‘compound’. Line 67. Change ‘are’ to ‘is’; or delete phrase “A new generation of …”. Lines 75 & 83. Change the word ‘arthropods’ to ‘insects’. Insects are the only arthropod capable of flight. Therefore flying arthropods are by default, flying insects. Line 109. :.. make test 30% test …” Remove the 1st test? Line 115. State the species of wild ticks that were collected in North Amherst, MA used to supplement the OSU colony ticks. Line 192. Something is missing in this sentence. Line 239. Species name should be written as lower case. Watch out for auto-correct. Lines 237 – 247. Authors switch from past tense to present tense, then back to past tense. Suggest sticking with just past tense in reporting results. There are 13 abbreviations used throughout this manuscript. Are they all necessary? If you only use a term once or twice (e.g., ULV) why is it necessary to mark it with an abbreviation? Likewise, it is never good to begin a sentence with an abbreviation. Just as the first word in a sentence should be capitalized, the subject of a sentence should be spelled out. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-14066R1Spatial repellents transfluthrin and metofluthrin affect the behavior of Dermacentor variabilis, Amblyomma americanum, and Ixodes scapularis in an in vitro vertical climb assayPLOS ONE Dear Dr. Rich, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address the very minor comments from the second reviewer, who brought up some items for clarification, particularly with Materials and Methods as you are describing a novel assay. I apologize for the delay, the original slate of reviewers were not all available. I look forward to your revision and will process it promptly. Please submit your revised manuscript by Nov 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Catherine A. Brissette, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #4: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Spatial repellents transfluthrin and metofluthrin affect the behavior of Dermacentor variabilis, Amblyomma americanum, and Ixodes scapularis in an in vitro vertical climb assay PONE-D-22-14066R2 Dear Dr. Rich, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Catherine A. Brissette, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .